Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vaglini

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Tumori|May 6, 1999
Peritoneal carcinomatosis: feature of dissemination. A reviewM Deraco, N Santoro, O Carraro, et al.
Tumori|June 30, 1985
Limb-salvage procedure in two patients with spindle cell carcinoma of the lower extremities using isolation perfusionM Vaglini, S Andreola, A Attili, et al.
Cancer|November 5, 1999
Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusionC R Rossi, M Foletto, F Di Filippo, et al.
Oncology Reports|May 20, 2011
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancerM Santinami, F Cascinelli, A Chiti, et al.
Tumori|December 31, 1988
HLA antigens in familial and sporadic cutaneous melanomaD Rovini, G Pellegris, N Cascinelli, et al.
Cancer|January 15, 1994
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalanM Vaglini, F Belli, M Ammatuna, et al.
Tumori|August 16, 2001
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical studyM Deraco, C R Rossi, E Pennacchioli, et al.
Tumori|September 1, 1996
Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancerM Vaglini, F Cascinelli, A Chiti, et al.
Annals of Surgical Oncology|January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanomaM Vaglini, F Belli, M Santinami, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1993
Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2F Arienti, F Belli, L Rivoltini, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Tumori|May 6, 1999
Peritoneal carcinomatosis: feature of dissemination. A reviewM Deraco, N Santoro, O Carraro, et al.
Tumori|June 30, 1985
Limb-salvage procedure in two patients with spindle cell carcinoma of the lower extremities using isolation perfusionM Vaglini, S Andreola, A Attili, et al.
Cancer|November 5, 1999
Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusionC R Rossi, M Foletto, F Di Filippo, et al.
Oncology Reports|May 20, 2011
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancerM Santinami, F Cascinelli, A Chiti, et al.
Tumori|December 31, 1988
HLA antigens in familial and sporadic cutaneous melanomaD Rovini, G Pellegris, N Cascinelli, et al.
Cancer|January 15, 1994
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalanM Vaglini, F Belli, M Ammatuna, et al.
Tumori|August 16, 2001
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical studyM Deraco, C R Rossi, E Pennacchioli, et al.
Tumori|September 1, 1996
Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancerM Vaglini, F Cascinelli, A Chiti, et al.
Annals of Surgical Oncology|January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanomaM Vaglini, F Belli, M Santinami, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1993
Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2F Arienti, F Belli, L Rivoltini, et al.
Pageof 7